12 October 2021 · A careful risk assessment should be done on the benefits of this off-label use to the mother, and the risks it poses to the fetus or neonate.
12 October 2021 · Tocilizumab and sarilumab can be used off-label to treat hospitalised patients with COVID-19. Breastfeeding can continue if these treatments are required.